Publications by authors named "Farah R Itani"

Article Synopsis
  • Multiple Sclerosis (MS) is a disease where the body's immune system mistakenly attacks the central nervous system, and researchers are studying certain immune cells called CD8 T cells that can help reduce disease symptoms.
  • In this study, scientists tested how these CD8 T cells work in a type of MS that comes and goes, using a mouse model.
  • They found out that certain CD8 T cells can lower the severity of the disease and reduce relapses, suggesting new ways to treat MS by using specific immune cell transfers or special infections to boost these helpful cells.
View Article and Find Full Text PDF

CD8 T-cells predominate in CNS lesions of MS patients and display oligoclonal expansion. However, the role of myelin-specific CD8 T-cells in disease remains unclear, with studies showing protective and pathogenic roles in EAE. We demonstrated a disease-suppressive function for CNS-specific CD8 T-cells in a model where the antigen is exogenously administered in vivo and used for in vitro activation.

View Article and Find Full Text PDF

The vast majority of studies regarding the immune basis of MS (and its animal model, EAE) have largely focused on CD4(+) T-cells as mediators and regulators of disease. Interestingly, CD8(+) T-cells represent the predominant T-cell population in human MS lesions and are oligoclonally expanded at the site of pathology. However, their role in the autoimmune pathologic process has been both understudied and controversial.

View Article and Find Full Text PDF

The role of CD8+ T cells in the process of autoimmune pathology has been both understudied and controversial. Multiple sclerosis (MS) is an inflammatory, demyelinating disorder of the central nervous system (CNS) with underlying T cell-mediated immunopathology. CD8+ T cells are the predominant T cells in human MS lesions, showing oligoclonal expansion at the site of pathology.

View Article and Find Full Text PDF